dc.contributor.author |
Sicuri, Elisa |
dc.contributor.author |
Evans, David B. |
dc.contributor.author |
Tediosi, Fabrizio |
dc.date |
2016-02-03T14:13:40Z |
dc.date |
2016-02-03T14:13:40Z |
dc.date |
2015-06-12 |
dc.date |
2016-02-02T15:34:10Z |
dc.identifier.citation |
1932-6203 |
dc.identifier.uri |
http://hdl.handle.net/2445/69206 |
dc.format |
21 p. |
dc.format |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Public Library of Science (PLoS) |
dc.relation |
Reproducció del document publicat a:
http://dx.doi.org/10.1371/journal.pone.0130603 |
dc.relation |
PloS one, 2015, vol. 10, num. 6, p. e0130603 |
dc.relation |
http://dx.doi.org/10.1371/journal.pone.0130603 |
dc.rights |
cc by (c) Sicuri et al., 2015 |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.rights |
http://creativecommons.org/licenses/by/3.0/es/ |
dc.subject |
Medicina preventiva |
dc.subject |
Malalties infeccioses |
dc.subject |
Cerca documental en línia |
dc.subject |
Anàlisi econòmica |
dc.subject |
Preventive medicine |
dc.subject |
Communicable diseases |
dc.subject |
Online bibliographic searching |
dc.subject |
Economic analysis |
dc.title |
Can Economic Analysis Contribute to Disease Elimination and
Eradication? A Systematic Review |
dc.type |
info:eu-repo/semantics/article |
dc.type |
info:eu-repo/semantics/publishedVersion |
dc.description.abstract |
BACKGROUND: Infectious diseases elimination and eradication have
become important areas of focus for global health and countries.
Due to the substantial up-front investments required to
eliminate and eradicate, and the overall shortage of resources
for health, economic analysis can inform decision making on
whether elimination/eradication makes economic sense and on the
costs and benefits of alternative strategies. In order to draw
lessons for current and future initiatives, we review the
economic literature that has addressed questions related to the
elimination and eradication of infectious diseases focusing on:
why, how and for whom? METHODS: A systematic review was
performed by searching economic literature (cost-benefit,
cost-effectiveness and economic impact analyses) on
elimination/eradication of infectious diseases published from
1980 to 2013 from three large bibliographic databases: one
general (SCOPUS), one bio-medical (MEDLINE/PUBMED) and one
economic (IDEAS/REPEC). RESULTS: A total of 690 non-duplicate
papers were identified from which only 43 met the inclusion
criteria. In addition, only one paper focusing on equity issues,
the "for whom?" question, was found. The literature relating to
"why?" is the largest, much of it focusing on how much it would
cost. A more limited literature estimates the benefits in terms
of impact on economic growth with mixed results. The question of
how to eradicate or eliminate was informed by an economic
literature highlighting that there will be opportunities for
individuals and countries to free-ride and that forms of
incentives and/or disincentives will be needed. This requires
government involvement at country level and global coordination.
While there is little doubt that eliminating infectious diseases
will eventually improve equity, it will only happen if active
steps to promote equity are followed on the path to elimination
and eradication. CONCLUSION: The largest part of the literature
has focused on costs and economic benefits of
elimination/eradication. To a lesser extent, challenges
associated with achieving elimination/eradication and ensuring
equity have also been explored. Although elimination and
eradication are, for some diseases, good investments compared
with control, countries' incentives to eliminate do not always
align with the global good and the most efficient elimination
strategies may not prioritize the poorest populations. For any
infectious disease, policy-makers will need to consider
realigning contrasting incentives between the individual
countries and the global community and to assure that the
process towards elimination/eradication considers equity. |